Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine as a Therapeutic Agent in Parkinson's Disease
NCT01738178Phase 3Completed
- Sponsor
- McGill University Health Centre
- Start
- Apr 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of caffeine in Parkinson's disease (PD), sponsored by McGill University Health Centre. Started Apr 2014; status: completed.
02
Drugs
caffeine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01738178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01738178.